These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 16168561
1. Steroid receptor expressions in endometrial cancer: clinical significance and epidemiological implication. Jeon YT, Park IA, Kim YB, Kim JW, Park NH, Kang SB, Lee HP, Song YS. Cancer Lett; 2006 Aug 08; 239(2):198-204. PubMed ID: 16168561 [Abstract] [Full Text] [Related]
2. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer. Ferrandina G, Ranelletti FO, Gallotta V, Martinelli E, Zannoni GF, Gessi M, Scambia G. Gynecol Oncol; 2005 Sep 08; 98(3):383-9. PubMed ID: 15979129 [Abstract] [Full Text] [Related]
3. A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma. Oreskovic S, Babic D, Kalafatic D, Barisic D, Beketic-Oreskovic L. Gynecol Oncol; 2004 Apr 08; 93(1):34-40. PubMed ID: 15047211 [Abstract] [Full Text] [Related]
4. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma. Suthipintawong C, Wejaranayang C, Vipupinyo C. J Med Assoc Thai; 2008 Dec 08; 91(12):1779-84. PubMed ID: 19133508 [Abstract] [Full Text] [Related]
5. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study. Wilder JL, Shajahan S, Khattar NH, Wilder DM, Yin J, Rushing RS, Beaven R, Kaetzel C, Ueland FR, van Nagell JR, Kryscio RJ, Lele SM. Gynecol Oncol; 2004 Feb 08; 92(2):553-8. PubMed ID: 14766247 [Abstract] [Full Text] [Related]
6. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma. Fukuda K, Mori M, Uchiyama M, Iwai K, Iwasaka T, Sugimori H. Gynecol Oncol; 1998 Jun 08; 69(3):220-5. PubMed ID: 9648591 [Abstract] [Full Text] [Related]
7. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium. Shabani N, Mylonas I, Jeschke U, Thaqi A, Kuhn C, Puchner T, Friese K. Anticancer Res; 2007 Jun 08; 27(4A):2027-33. PubMed ID: 17649817 [Abstract] [Full Text] [Related]
8. Stepwise abnormality of sex steroid hormone receptors, tumor suppressor gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma. Li SF, Shiozawa T, Nakayama K, Nikaido T, Fujii S. Cancer; 1996 Jan 15; 77(2):321-9. PubMed ID: 8625241 [Abstract] [Full Text] [Related]
9. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer. Jongen V, Briët J, de Jong R, ten Hoor K, Boezen M, van der Zee A, Nijman H, Hollema H. Gynecol Oncol; 2009 Mar 15; 112(3):537-42. PubMed ID: 19108875 [Abstract] [Full Text] [Related]
10. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas. Leers MP, Hoop JG, van Beers M, van Rodijnen N, Pannebakker M, Nap M. Cytometry B Clin Cytom; 2005 Mar 15; 64(1):43-52. PubMed ID: 15668953 [Abstract] [Full Text] [Related]
11. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study. Høgdall EV, Christensen L, Høgdall CK, Blaakaer J, Gayther S, Jacobs IJ, Christensen IJ, Kjaer SK. Oncol Rep; 2007 Nov 15; 18(5):1051-9. PubMed ID: 17914554 [Abstract] [Full Text] [Related]
12. Cyclooxygenase-2 and p53 expressions in endometrial cancer. Jeon YT, Kang S, Kang DH, Yoo KY, Park IA, Bang YJ, Kim JW, Park NH, Kang SB, Lee HP, Song YS. Cancer Epidemiol Biomarkers Prev; 2004 Sep 15; 13(9):1538-42. PubMed ID: 15342458 [Abstract] [Full Text] [Related]
13. Significance of progesterone receptor-A and -B expressions in endometrial adenocarcinoma. Miyamoto T, Watanabe J, Hata H, Jobo T, Kawaguchi M, Hattori M, Saito M, Kuramoto H. J Steroid Biochem Mol Biol; 2004 Oct 15; 92(3):111-8. PubMed ID: 15555905 [Abstract] [Full Text] [Related]
14. Prognostic value of estrogen receptor and progesterone receptor status in young Chinese ovarian carcinoma patients. Yang XY, Xi MR, Yang KX, Yu H. Gynecol Oncol; 2009 Apr 15; 113(1):99-104. PubMed ID: 19178934 [Abstract] [Full Text] [Related]
15. Gonadotropin-releasing hormone receptor expression in endometrial cancer. Jeon YT, Kim YB, Park SY, Kim JW, Park NH, Kang SB, Song YS. Int J Gynecol Pathol; 2009 Jan 15; 28(1):19-22. PubMed ID: 19047913 [Abstract] [Full Text] [Related]
16. Epithelial and stromal estrogen and progesterone receptor expression in endometrial cancer: true color computer-assisted image analysis versus subjective scoring. Kohlberger PD, Kieback DG, Breitenecker F, Loesch A, Gitsch G, Kainz C, Breitenecker G. Gynecol Oncol; 1997 Mar 15; 64(3):404-10. PubMed ID: 9062141 [Abstract] [Full Text] [Related]
17. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions]. Ma XX, Zhang SL, Gao S, Lu JM, Dong F. Zhonghua Fu Chan Ke Za Zhi; 2006 Jun 15; 41(6):395-8. PubMed ID: 16831363 [Abstract] [Full Text] [Related]
20. Expression of HPV, steroid receptors (ERalpha, ERbeta, PR-A and PR-B) and inhibin/activin subunits (alpha, betaA and betaB) in adenosquamous endometrial carcinoma. Gingelmaier A, Gutsche S, Mylonas I, Shabani N, Kuhn C, Kunze S, Jeschke U, Friese K. Anticancer Res; 2007 Jun 15; 27(4A):2011-7. PubMed ID: 17649814 [Abstract] [Full Text] [Related] Page: [Next] [New Search]